Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia

Leukemia. 2012 Sep;26(9):2144-6. doi: 10.1038/leu.2012.74. Epub 2012 Mar 19.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Child
  • Humans
  • Janus Kinase 3 / genetics*
  • Male
  • Middle Aged
  • Mutation / genetics*
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / genetics*
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / mortality
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / therapy
  • Prognosis
  • Survival Rate

Substances

  • JAK3 protein, human
  • Janus Kinase 3